Ribon Therapeutics Named a “Fierce 15” Biotech Company by Fierce Biotech

Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, today announced it has been named by Fierce Biotech as one of 2021s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.